A Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fasting Conditions
Status:
Completed
Trial end date:
2004-10-01
Target enrollment:
Participant gender:
Summary
To compare the rate of absorption and oral bioavailability of a test formulation of
Ramipril10 mg Capsules manufactured by Purepac Pharmaceutical Company to an equivalent oral
dose of the commercially available reference product Atlace® manufactured by Monarch
Pharmaceuticals Inc. administrated to healthy subjects after a 10-hour overnight fast